Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.69 +1.48 (+3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Price to Earnings (2022 - 2026)

Updated

Bright Minds Biosciences' (DRUG) Price to Earnings came in at 129.50 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 350.6% from 28.74 a year earlier and up 124.4% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Price to Earnings (2022 - 2026) Analysis & Trends

For FY2023 (ended Sep 30, 2023), Bright Minds Biosciences' Price to Earnings stood at 5.60.

  • The fiscal Q3 2026 figure stands as the highest quarterly Price to Earnings since fiscal Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Bright Minds Biosciences 387.06 Mn 387.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 129.50
Mar 31, 2026 57.70
Jun 30, 2025 28.74
Mar 31, 2025 259.41
Jun 30, 2024 1.86
Mar 31, 2024 5.62
Dec 31, 2023 1.94
Sep 30, 2023 1.85
Jun 30, 2023 1.59
Mar 31, 2023 0.72
Dec 31, 2022 3.61
Sep 30, 2022 3.26
API Access

Bright Minds Biosciences Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=DRUG&period=max&api_key=YOUR_API_KEY